54.05
Akero Therapeutics Inc Aktie (AKRO) Neueste Nachrichten
Can Akero Therapeutics Inc. (0K4) stock deliver strong annual returnsGold Moves & High Yield Equity Trading Tips - newser.com
Will Akero Therapeutics Inc. (0K4) stock rise with strong economy2025 Volatility Report & Real-Time Chart Pattern Alerts - newser.com
Heatmap analysis for Akero Therapeutics Inc. and competitorsIPO Watch & Fast Moving Market Watchlists - newser.com
Is Akero Therapeutics Inc. stock a buy before product launchesWeekly Trade Review & Weekly Watchlist for Hot Stocks - newser.com
Can Akero Therapeutics Inc. (0K4) stock beat analyst consensusEarnings Overview Summary & Consistent Growth Stock Picks - newser.com
Will Akero Therapeutics Inc. stock gain from lower inflationTrade Risk Assessment & Precise Entry and Exit Recommendations - newser.com
Why Akero Therapeutics Stock Trounced the Market on Thursday - AOL.com
Using RSI to spot recovery in Akero Therapeutics Inc.Gap Up & Expert Curated Trade Setups - newser.com
Chart based analysis of Akero Therapeutics Inc. trendsWeekly Market Outlook & Entry Point Confirmation Signals - newser.com
Is Akero Therapeutics Inc. stock a top pick in earnings seasonPortfolio Risk Summary & Technical Entry and Exit Alerts - newser.com
How high can Akero Therapeutics Inc. stock go2025 AllTime Highs & Low Drawdown Investment Ideas - newser.com
Jennison Associates LLC Grows Stock Position in Akero Therapeutics, Inc. $AKRO - MarketBeat
Will Akero Therapeutics Inc. stock reach Wall Street targetsAnalyst Downgrade & High Conviction Buy Zone Alerts - newser.com
Y Intercept Hong Kong Ltd Takes Position in Akero Therapeutics, Inc. $AKRO - MarketBeat
Akero Therapeutics, Inc. (NASDAQ:AKRO) Short Interest Update - MarketBeat
Will Akero Therapeutics Inc. outperform the market2025 Support & Resistance & Fast Entry Momentum Alerts - newser.com
Fatty liver disease companies' multibillion-dollar deals mean fatter walletsSan Francisco Business Times - The Business Journals
Can volume confirm reversal in Akero Therapeutics Inc.2025 Fundamental Recap & Daily Stock Momentum Reports - newser.com
Is Akero Therapeutics Inc. trending in predictive chart modelsJuly 2025 Levels & Weekly High Return Opportunities - newser.com
Emerald Mutual Fund Advisers Trust Has $7.27 Million Stock Position in Akero Therapeutics, Inc. $AKRO - MarketBeat
Is Akero Therapeutics Inc. (0K4) stock included in top ETFsJuly 2025 Trends & Stepwise Trade Signal Guides - newser.com
Can Akero Therapeutics Inc. (0K4) stock surprise with quarterly resultsChart Signals & Entry Point Confirmation Alerts - newser.com
Why Akero Therapeutics Inc. stock is recommended by analystsTrade Analysis Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Altimmune: Competitor Buyouts Plus Regulatory And Clinical Progress (NASDAQ:ALT) - Seeking Alpha
Akero Stock Hits Over 18-Month High On MASH Trial Data: Citi Lauds ‘Best-Case Scenario,’ Retail Exuberant - MSN
Berger Montague PC Investigates Akero Therapeutics, Inc. and Its Board of Directors for Breach of Fiduciary Duties and Violations of Federal Securities Laws (NASDAQ: AKRO) - Lelezard
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):